Derivation of Mature Oocytes from Human Primordial Follicles
Derivation of Mature Oocytes from Human Primordial Follicles
批准号:
7964577
负责人:
AARON JW HSUEH
金额:
$23.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2011-08-31
关键词:
AdultAnimal ModelAnimal TestingAntralCancer PatientClinicalDNADNA Microarray ChipDataDerivation procedureDevelopmentEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEvaluationExclusionExploratory/Developmental Grant for Diagnostic Cancer ImagingFemaleFertilityFertilizationFreezingFutureGene Expression ProfileGenerationsGenesGeneticGerm CellsGonadotropinsGrowthGrowth FactorHormonalHumanImmuneIn VitroIncubatedIndividualInfertilityKidneyMalignant NeoplasmsMalignant neoplasm of ovaryMenopauseMusMutant Strains MiceNeonatalNuclearNude MiceOocytesOvarianOvarian FollicleOvarian TissueOvaryPatientsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPopulation HeterogeneityPregnancyPremature Ovarian FailurePrimordial FollicleProceduresProteinsProtocols documentationPublic HealthRNARadiation therapyRecruitment ActivityReportingResearch Project GrantsResidual stateRetrievalRodentSCID MiceSafetySecondary toSignal PathwayStagingSystemTestingTissuesTransplantationTumor Suppressor ProteinsVesicleWomanXenobaseblastocystcapsulecomparative genomic hybridizationgenome-widein vivoinhibitor/antagonistinnovationintraovarianmature animalneonatal exposureparacrineprematureprogramspublic health relevanceresponsesuccesstensin
中文摘要
描述(由申请人提供):从人原始卵泡中获得成熟卵母细胞在女性中,大多数卵泡在原始阶段保持休眠数十年,并且这种休眠池的消耗导致绝经。由于遗传和环境的影响,一些女性患有与卵泡储备减少相关的卵巢早衰/功能不全。在生理条件下,未表征的卵巢内机制每月激活约1,000个休眠的原始卵泡开始生长,而剩余的卵泡保持静止数年或数十年。原始卵泡一旦进入生长池,就会以最小的损失继续生长到早期窦期。在早期窦期,选择卵泡对促性腺激素产生反应,一个排卵前卵泡释放成熟卵母细胞进行受精。使用突变小鼠的研究表明,卵母细胞特异性缺失PTEN(具有TENSin同源性的肿瘤抑制磷酸酶)基因或下游转录因子Foxo 3促进所有原始卵泡的生长。PTEN基因编码负调节磷酸肌醇3-激酶(PI 3 K)和Akt信号传导途径的磷酸酶。卵母细胞中PTEN的缺失增加Akt的磷酸化和下游Foxo 3蛋白的核排斥,导致所有休眠的原始卵泡的激活。利用PTEN抑制剂的可用性,我们激活了小鼠的原始卵泡。新生小鼠卵巢在体外短暂暴露于PTEN抑制剂后,移植到FSH处理的成年受体的肾包膜中,卵泡生长显着增加。成熟的卵母细胞可以从这些卵巢中取出体外受精和囊胚形成。我们的初步数据也证明了PTEN抑制剂在激活由癌症患者捐赠的皮质条中的休眠人类原始卵泡以产生成熟卵母细胞中的功效。斯坦福大学的生育和癌症项目已经储存了冷冻的人类卵巢皮质带,其中主要含有来自癌症患者的原始卵泡。在这里,我们建议在体外孵育人类卵泡与PTEN抑制剂和旁分泌因子,然后移植到免疫缺陷小鼠,以优化卵泡激活方法的成熟人类卵母细胞的衍生。将对移植后生成的单个成熟卵母细胞进行染色体完整性研究,以确定本程序的安全性。此外,我们将使用两步体外培养的方法来处理小鼠新生儿卵巢和人类皮质带与PTEN抑制剂和卵巢旁分泌生长因子的休眠卵泡的激活,然后在体外促进其生长的次级和腔前卵泡使用阶段特异性旁分泌因子。在第二步中,我们将分离腔前卵泡,并将其与各种卵巢旁分泌因子一起培养,以促进其发育为含有成熟卵母细胞的腔卵泡。我们将进一步研究来自体外培养的单个成熟卵母细胞的染色体完整性,并进一步扩增来自单个成熟卵母细胞的RNA用于DNA微阵列分析以揭示转录组变化。尽管卵巢早衰患者和围绝经期妇女的生育能力受到影响,但他们的卵巢仍然含有许多原始卵泡。目前的体外卵泡激活方法,然后进行自体移植,可以为卵巢储备减少的不孕妇女和癌症患者获取功能成熟的卵母细胞。未来发展的两步培养方法,使原始卵泡发育到窦期,然后产生成熟的卵母细胞,可能对治疗不同人群的卵巢不孕症的妇女有重要的临床意义。
公共卫生相关性:卵巢早衰的患者或女性癌症患者在化疗或放疗后遭受卵巢生殖细胞的损失和不育。本申请涉及使用酶抑制剂和关键卵巢生长因子来启动休眠的人卵泡的生长,用于随后衍生成熟卵母细胞。一旦优化,本方法可以允许激活来自卵巢早衰患者或围绝经期妇女的残留原始卵泡,以产生用于不孕症治疗的成熟卵母细胞。在化疗或放疗前冷冻癌症患者的卵巢也可以用来产生成熟的卵母细胞用于不孕症治疗。
英文摘要
DESCRIPTION (provided by applicant): Derivation of mature oocytes from human primordial follicles The majority of ovarian follicles stay dormant at the primordial stage for decades in women and the depletion of this dormant pool leads to menopause. Due to genetic and environmental influences, some women suffer from premature ovarian failure/insufficiency associated with a diminishing follicle reserve. Under physiological conditions, uncharacterized intraovarian mechanisms activate ~1,000 dormant primordial follicles to initiate growth per month, whereas the remaining follicles stay quiescent for years or decades. Once recruited into the growing pool, primordial follicles continue growth to the early antral stage with minimal loss. At the early antral stage, select follicles respond to gonadotropins and one preovulatory follicle release the mature oocyte for fertilization. Studies using mutant mice indicated that oocyte-specific deletion of the PTEN (Tumor-suppressor phosphatase with TENsin homology) gene or the downstream transcriptional factor Foxo3 promoted the growth of all primordial follicles. The PTEN gene encodes a phosphatase enzyme that negatively regulates the phosphoinositol 3-kinase (PI3K) and Akt signaling pathway. Deletion of PTEN in the oocyte increases the phosphorylation of Akt and the nuclear exclusion of the downstream Foxo3 proteins, leading to the activation of all dormant primordial follicles. Taking advantage of the availability of PTEN inhibitors, we activated primordial follicles in mice. Neonatal mouse ovaries exposed transiently to PTEN inhibitors in vitro showed marked increases in follicle growth after transplantation into the kidney capsule of FSH-treated adult recipients. Mature oocytes could be retrieved from these ovaries for IVF and blastocyst formation. Our preliminary data also demonstrated the efficacy of the PTEN inhibitor in activating dormant HUMAN primordial follicles in cortical strips donated by a cancer patient to yield mature oocytes. The Fertility and Cancer program at Stanford have stored frozen human ovarian cortical strips containing mainly primordial follicles from cancer patients. Here, we propose to incubate human follicles in vitro with PTEN inhibitors and paracrine factors, followed by transplantation into immune-deficient mice to optimize the follicle activation approach for the derivation of mature human oocytes. Chromosomal integrity will be investigated for individual mature oocytes generated after transplantation to determine the safety of the present procedure. In addition, we will use a two-step in vitro culture approach to treat mouse neonatal ovaries and human cortical strips with PTEN inhibitor and ovarian paracrine growth factors for the activation of dormant follicles, followed by the in vitro promotion of their growth to secondary and preantral follicles using stage-specific paracrine factors. During the second step, we will isolate preantral follicles and culture them with diverse ovarian paracrine factors to promote their development into antral follicles containing mature oocytes. We will further investigate the chromosomal integrity of individual mature oocytes derived from in vitro cultures and further amplify RNA from individual mature oocytes for DNA microarray analyses to reveal transcriptome changes. Although fertility is compromised in patients with premature ovarian failure and peri-menopausal women, their ovaries still contain many primordial follicles. The present in vitro follicle activation approach, followed by auto- transplantation, could allow retrieval of functional mature oocytes for infertile women with diminishing ovarian reserve and for cancer patients. Future development of a two-step culture approach to allow the development of primordial follicles to the antral stage, followed by the generation of mature oocytes, could have important clinical implications for the treatment of ovarian infertility in diverse population of women.
PUBLIC HEALTH RELEVANCE: Patients with premature ovarian failure or female cancer patients following chemo- or radiation therapy suffer from the loss of ovarian germ cells and infertility. The present application deals with the use of enzyme inhibitors and key ovarian growth factors to initiate the growth of dormant human ovarian follicles for subsequent derivation of mature oocytes. Once optimized, the present approach could allow the activation of residual primordial follicles from patients with premature ovarian failure or peri-menopausal women to generate mature oocytes for infertility treatment. Frozen ovaries from cancer patients before chemo- or radiation therapy could also be used to generate mature oocytes for infertility treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oocyte-derived R-spondin2 as a Follicle Stimulating Hormone
-
批准号:8526219
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2012
-
负责人:AARON JW HSUEH
-
依托单位:
Oocyte-derived R-spondin2 as a Follicle Stimulating Hormone
-
批准号:8368062
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2012
-
负责人:AARON JW HSUEH
-
依托单位:
Oocyte factors for reprogramming to pluripotency
-
批准号:7815481
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2010
-
负责人:AARON JW HSUEH
-
依托单位:
Activation of dormant ovarian follicles
-
批准号:7640438
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2009
-
负责人:AARON JW HSUEH
-
依托单位:
Activation of dormant ovarian follicles
-
批准号:7849497
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2009
-
负责人:AARON JW HSUEH
-
依托单位:
Identification of ligand signaling for the stem cell marker LGR5
-
批准号:7632206
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2008
-
负责人:AARON JW HSUEH
-
依托单位:
Identification of ligand signaling for the stem cell marker LGR5
-
批准号:7510574
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2008
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:6873661
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:6745135
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:7055339
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:7224802
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
Physiology of LGR7 and LGR8 in Gonadal Tissues
-
批准号:6605276
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2003
-
负责人:AARON JW HSUEH
-
依托单位:
G Protein-Coupled Receptors with Leucine-Rich Repeats
-
批准号:6400133
-
项目类别:
-
资助金额:$15.71万
-
财政年份:2001
-
负责人:AARON JW HSUEH
-
依托单位:
G Protein-Coupled Receptors with Leucine-Rich Repeats
-
批准号:6517827
-
项目类别:
-
资助金额:$15.71万
-
财政年份:2001
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:2471427
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:6682944
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
STRUCTURE/FUNCTIONAL ANALYSIS OF INHIBIN
-
批准号:2026393
-
项目类别:
-
资助金额:$8.05万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:2888950
-
项目类别:
-
资助金额:$21.83万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:6387532
-
项目类别:
-
资助金额:$22.88万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
BIOACTIVE FSH AND REPRODUCTION
-
批准号:6406960
-
项目类别:
-
资助金额:$27.62万
-
财政年份:1997
-
负责人:AARON JW HSUEH
-
依托单位:
海外基金